AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

US biotech company SparX Biopharmaceutical has signed a research agreement with Mitsubishi Tanabe Pharma America aimed at ...

He will discuss how Kernel, a software design tool that powers Asimov’s CHO Edge system, can accelerate timelines and improve titers for cell line and process development. The webinar will cover ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical ...

ProBioGen inks agreement with Polpharma Biologics to provide high-performance cell line development services: Gdansk, Poland Friday, May 9, 2025, 17:00 Hrs [IST] ProBioGen, a Berl ...

Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of ...

The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...

Developing orphan drugs involves navigating intricate regulatory landscapes, financial risks, and limited clinical data. To ...